Spero Therapeutics News

Spero Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Anson Funds Management LP(6.9%),Anson Management GP LLC(6.9%), etc.

Nov 14 17:41 ET

Spero Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 14 17:15 ET

Spero Therapeutics | 8-K: Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update

Nov 14 17:03 ET

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rajavelu Esther

Nov 12 16:42 ET

Spero Therapeutics | 8-K: Current report

Oct 29 17:04 ET

Spero Therapeutics | 8-K: Current report

Sep 10 06:58 ET

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mahadevia Ankit

Aug 29 18:45 ET

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Keutzer Timothy

Aug 29 18:45 ET

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Shukla Sath

Aug 29 18:41 ET

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Shukla Sath

Aug 6 19:58 ET

Spero Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 5 16:28 ET

Spero Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 5 16:22 ET

Spero Therapeutics | 8-K: Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update

Aug 5 16:20 ET

Spero Therapeutics | 8-K: Current report

Jun 3 16:27 ET

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Deshpande Milind

May 30 16:35 ET

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Jackson Scott Thomas

May 30 16:34 ET

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pottage John C Jr

May 30 16:32 ET

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director THOMAS FRANK E

May 30 16:32 ET

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Smith Cynthia

May 30 16:32 ET

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director VINK PATRICK V.J.J.

May 30 16:28 ET